Abstract: The concept of cancer stem cells has revolutionized our current vision of cancer development and was validated in solid tumors and cancers of the primitive hematopoietic compartment. Proof of the principle is still lacking, however, in malignancies of differentiated B-cells. We review here the current literature, which nevertheless suggests hierarchical organizations of the tumor clone for mostly incurable B-cell cancers such as multiple myeloma, lymphomas and B-chronic lymphocytic leukemia. We propose two models accounting for cancer stem cells in these contexts: a “top-to-bottom” clonal hierarchy from memory B-cells and a “bottom-to-top” model of clonal reprogramming. Selection pressure on the growing tumor can drive such reprogramming and increase its genetic diversity.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Gross, E.; Quillet-Mary, A.; Ysebaert, L.; Laurent, G.; Fournie, J.-J. Cancer Stem Cells of Differentiated B-Cell Malignancies: Models and Consequences. Cancers 2011, 3, 1566-1579.
Gross E, Quillet-Mary A, Ysebaert L, Laurent G, Fournie J-J. Cancer Stem Cells of Differentiated B-Cell Malignancies: Models and Consequences. Cancers. 2011; 3(2):1566-1579.
Gross, Emilie; Quillet-Mary, Anne; Ysebaert, Loic; Laurent, Guy; Fournie, Jean-Jacques. 2011. "Cancer Stem Cells of Differentiated B-Cell Malignancies: Models and Consequences." Cancers 3, no. 2: 1566-1579.